December 17, 2025 — Thermo Fisher Scientific Inc. (NYSE: TMO) is back in focus for stock investors on Wednesday as a wave of institutional filing headlines hits the tape alongside a busy run of analyst upgrades and price-target increases from early December.

At the same time, Thermo Fisher’s long-term equity story remains tied to the same big themes: demand for tools and services used across drug development, bioprocessing, diagnostics, and lab operations, plus the company’s steady cadence of portfolio moves and capital returns.

Below is a complete, news-style roundup of what’s moving Thermo Fisher Scientific stock today, what analysts are forecasting next, and the key catalysts investors are tracking.

TMO stock price today

Thermo…